| Tretinoin | Approved Investigational Nutraceutical | IRX3 | 79191 |
upregulated | Tretinoin results in increased expression of IRX3 mRNA | 16q12.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ISG15 | 9636 |
upregulated | Tretinoin results in increased expression of ISG15 mRNA | 1p36.33 | |
| Tretinoin | Approved Investigational Nutraceutical | ISL1 | 3670 |
downregulated | Tretinoin results in decreased expression of ISL1 mRNA | 5q11.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ISL1 | 3670 |
upregulated | Tretinoin results in increased expression of ISL1 mRNA | 5q11.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ISLR2 | 57611 |
upregulated | Tretinoin results in increased expression of ISLR2 mRNA | 15q24.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ISOC1 | 51015 |
downregulated | Tretinoin results in decreased expression of ISOC1 mRNA | 5q23.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ISYNA1 | 51477 |
upregulated | Tretinoin results in increased expression of ISYNA1 mRNA | 19p13.11 | |
| Tretinoin | Approved Investigational Nutraceutical | ITGA1 | 3672 |
upregulated | Tretinoin results in increased expression of ITGA1 mRNA | 5q11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ITGA2 | 3673 |
upregulated | Tretinoin results in increased expression of ITGA2 mRNA | 5q11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ITGA4 | 3676 |
upregulated | Tretinoin metabolite results in increased expression of ITGA4 mRNA | 2q31.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ITGA4 | 3676 |
downregulated | Tretinoin results in decreased expression of ITGA4 mRNA | 2q31.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ITGA4 | 3676 |
upregulated | Tretinoin results in increased expression of ITGA4 mRNA | 2q31.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ITGA6 | 3655 |
upregulated | Tretinoin results in increased expression of ITGA6 mRNA | 2q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ITGA8 | 8516 |
upregulated | Tretinoin results in increased expression of ITGA8 mRNA | 10p13 | |
| Tretinoin | Approved Investigational Nutraceutical | ITGA9 | 3680 |
upregulated | Tretinoin results in increased expression of ITGA9 mRNA | 3p22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ITGAM | 3684 |
upregulated | Tretinoin results in increased expression of ITGAM mRNA | 16p11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ITGAX | 3687 |
upregulated | Tretinoin results in increased expression of ITGAX mRNA | 16p11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ITGB1 | 3688 |
upregulated | Tretinoin results in increased expression of ITGB1 mRNA | 10p11.22 | |
| Tretinoin | Approved Investigational Nutraceutical | ITGB1BP1 | 9270 |
upregulated | Tretinoin results in increased expression of ITGB1BP1 mRNA | 2p25.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ITGB1BP2 | 26548 |
downregulated | Tretinoin results in decreased expression of ITGB1BP2 mRNA | Xq13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ITGB2 | 3689 |
upregulated | Tretinoin results in increased expression of ITGB2 mRNA | 21q22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ITGB7 | 3695 |
upregulated | Tretinoin results in increased expression of ITGB7 mRNA | 12q13.13 | |
| Tretinoin | Approved Investigational Nutraceutical | ITM2A | 9452 |
downregulated | Tretinoin results in decreased expression of ITM2A mRNA | Xq21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ITM2A | 9452 |
upregulated | Tretinoin results in increased expression of ITM2A mRNA | Xq21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ITM2B | 9445 |
upregulated | Tretinoin results in increased expression of ITM2B mRNA | 13q14.2 | |